Compare Reliance Sekuritas Indonesia Tbk. (RELI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Reliance Sekuritas Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Reliance Sekuritas Indonesia Tbk. trades at Rp560 (market cap 999B, 33.8K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Reliance Sekuritas Indonesia Tbk. is far larger — about 9.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| RELI | SCPI | |
|---|---|---|
Market Cap | 999B | 104.4B |
Volume | 33.8K | — |
Lot | 338 | — |
Turnover | 18.78M | — |
Average Price | 555.58 | — |
Value | 18.78M | — |
Indicative Equilibrium Price | 560 | — |
Indicative Equilibrium Volume | 1 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Reliance Sekuritas Indonesia Tbk.
PT. Reliance Securities (the company) was established under its original name of Istethmar Finas Securities on 22 Feb 1993 then changed to PT Ludlow Securities on 13 Sep 1999. According with Notaries deed on 28 March 2003 company's name changed to PT Reliance Securities. And the company's name changed to PT Reliance Securities Tbk on 19 May 2005 with amended the articles of association no 19 dated 14 April 2005.
Read more on RELI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
